Cannabis does not treat or cure pancreatic cancer: THC slowed pancreatic tumors in mice and CBD helped a chemotherapy drug work longer in mice, but no human trial has shown any anticancer effect. For people with pancreatic cancer, cannabinoids may help chemotherapy nausea that other drugs have not controlled. Trials for cancer pain and appetite loss, two major problems in this disease, have been disappointing.
Pancreatic cancer is one of the hardest cancers to treat, which makes patients and families understandably open to anything that sounds promising. Two well-known mouse studies have been widely shared as if they showed a cure. This page explains what they found, what has and has not been tested in people, and where cannabis may help with symptoms, as of October 2026. It is part of our overview of cannabis and cancer research.
Evidence at a Glance
| Claim | Evidence level | Source |
|---|---|---|
| THC triggers death of pancreatic cancer cells and slows mouse tumors | Preclinical only | Carracedo 2006 |
| CBD plus gemcitabine extends survival | Preclinical only (mice) | Ferro 2018 |
| Cannabis treats pancreatic cancer in people | No human evidence | ASCO 2024 |
| Cannabinoids ease refractory chemotherapy nausea | Strong; FDA-approved drugs | FDA, NASEM 2017 |
| Cannabinoids improve cancer appetite loss and weight | Weak; major trials negative | Strasser 2006 |
| Cannabinoids reduce cancer pain beyond opioids | Moderate evidence of no meaningful benefit | Cochrane 2023 |
What Lab and Animal Studies Found
THC and pancreatic tumor cells (2006)
A Spanish and French team published the best-known study in Cancer Research. In the MiaPaCa2 and Panc1 human pancreatic cancer cell lines, cannabinoids triggered programmed cell death through the CB2 receptor and a stress pathway involving ceramide, a fat molecule that signals cells to die. Cannabinoids also slowed tumor growth and spread in two mouse models, and the effect was selective: tumor cells died while normal pancreatic tissue was spared. The authors suggested this could form a basis for a new therapy. No published randomized human trial has tested the idea since.
CBD with gemcitabine (2018)
A team at Queen Mary University of London studied a receptor called GPR55 in pancreatic cancer. In a genetically engineered mouse model of the disease, mice that got CBD plus the chemotherapy drug gemcitabine survived nearly three times longer than mice given gemcitabine alone or no treatment. The authors proposed testing the combination in clinical trials. Headlines at the time described it as a breakthrough, but it remains a mouse result. Mouse survival is measured in weeks, and many drugs that extend it fail in people.
Why the leap to humans is hard
NCI’s PDQ summary notes that cannabinoid anticancer effects vary across models and that THC can suppress antitumor immunity in mice with intact immune systems. Doses used in animals may not be reachable or tolerable in people, and pancreatic tumors are notoriously resistant to drugs reaching them.
Is There Human Evidence for Pancreatic Cancer?
No. There are no published randomized human trials testing cannabis, THC or CBD against pancreatic cancer. The National Academies found insufficient evidence that cannabinoids treat any cancer. ASCO’s 2024 guideline advises clinicians to recommend against cannabis as a cancer-directed treatment unless it is part of a clinical trial. If you are interested in experimental options, a clinical trial is the safe way to access them; NCI keeps a searchable trial database.
Does Cannabis Cause Pancreatic Cancer?
There is no good evidence either way. The National Academies’ 2017 review did not find enough research to reach any conclusion on cannabis use and pancreatic cancer risk, and the larger risk studies, summarized in a 2019 JAMA Network Open meta-analysis, focused mainly on lung, head and neck and testicular cancers. Tobacco smoking is a well-established pancreatic cancer risk factor, so cannabis mixed with tobacco in blunts or spliffs carries that risk.
Symptom Relief: Where Cannabinoids May Fit
Nausea and vomiting
Pancreatic cancer chemotherapy regimens such as FOLFIRINOX can cause significant nausea. The FDA approved dronabinol and nabilone for chemotherapy nausea and vomiting that does not respond to standard antiemetics, and the National Academies rated the evidence for oral cannabinoids in this use as conclusive. ASCO supports cannabinoids for refractory nausea as an add-on to guideline-based antiemetics, not a replacement.
Appetite loss and weight loss
Cachexia, the severe weight and muscle loss common in pancreatic cancer, is where many patients hope cannabis will help. The trials do not support it. A 243-patient phase III trial found no difference in appetite or quality of life between cannabis extract, THC and placebo, and was stopped early. In a 469-patient trial, megestrol improved appetite more than dronabinol. The National Academies rated the evidence for cancer cachexia as insufficient. Some individuals still report better appetite, which is worth discussing with a palliative care team.
Pain
Pancreatic cancer pain is often severe and treated with opioids and nerve blocks. A 2023 Cochrane review found moderate-certainty evidence that nabiximols and THC did not reduce opioid-resistant cancer pain more than placebo, and a 2020 meta-analysis found more drowsiness and dizziness with cannabinoids. Cannabis should not replace a pain plan from your care team.
Sleep and anxiety
Many patients report better sleep and less anxiety. NCI describes the clinical evidence as limited to small studies.
Risks and Side Effects
- Delaying treatment. Pancreatic cancer moves fast; time spent on unproven remedies can close treatment windows.
- Drug interactions. CBD inhibits liver enzymes that process many drugs. NCI warns that concentrated CBD oils could change chemotherapy toxicity or effectiveness. The mouse study combining CBD with gemcitabine does not tell you a safe human dose.
- Sedation and confusion, especially combined with opioids. Falls are a risk for people who are already weak.
- Low blood pressure and fast heart rate, which can be worse with dehydration from vomiting or poor intake.
- Cannabinoid hyperemesis. Heavy, long-term use can cause cycles of severe vomiting, according to NIDA, which can be confused with treatment side effects.
- Smoke. The CDC notes cannabis smoke carries many of the same toxins as tobacco smoke. Oral forms avoid this; see our guide to tinctures.
Talk to Your Doctor
Ask your oncologist or palliative care team before starting cannabis. Bring the product label so they can see the THC and CBD content. Ask whether a prescription cannabinoid fits your nausea, how cannabis might interact with your chemotherapy and pain medicines, and whether a clinical trial is open to you. ASCO’s guideline asks oncologists to discuss cannabis without judgment, so you should not have to hide it. For buying legally in the Northwest, see our Washington and Oregon dispensary directories.
Pancreatic Cancer and Cannabis FAQ
Can CBD cure pancreatic cancer?
No. CBD combined with gemcitabine extended survival in mice, but it has not been shown to treat pancreatic cancer in people.
Does THC kill pancreatic cancer cells?
In lab dishes and mice, yes, cannabinoids triggered pancreatic cancer cell death. No human study has shown the same effect.
Can cannabis help with weight loss from pancreatic cancer?
The evidence is weak. A large phase III trial found cannabis extract and THC no better than placebo for appetite, and megestrol beat dronabinol in another trial.
Does marijuana help pancreatic cancer pain?
Controlled trials have not shown a meaningful benefit over placebo when added to opioids, though some patients report relief. Talk to your palliative care team.
Are there clinical trials of cannabis for pancreatic cancer?
Researchers have called for them. Check the NCI clinical trials database or ask your cancer center for current cannabinoid studies.
For adults 21+ in legal states. General information, not medical advice. Talk to a doctor before using cannabis for a health condition.
